drugset / Trial / NCT03935152

Oral Dydrogesterone in the Management of Preterm Labor

NCT03935152

Phase 4 Completed 48 enrolled Chulalongkorn University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the addition of oral dydrogesterone to standard treatment in the treatment of preterm labor. Half of participants will receive oral dydrogesterone and standard treatment, while the other half will receive oral placebo and standard treatment.

Timeline

Start
2019-05-11
Primary completion
2020-05-31
Completion
2020-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dydrogesterone Other / unclassified 10 mg Oral

Indications

No indication recorded.